Hunan Fangsheng Pharmaceutical News

Fangsheng Pharmaceutical: Investor Relations Activity Record Form (2024-040)

Nov 7 04:32 ET

Fangsheng Pharmaceutical: Investor Relations Activity Record Form (2024-038, 39)

Oct 29 21:30 ET

Fangsheng Pharmaceutical\'s announcement on the holding of the results briefing for the third quarter of 2024

Oct 29 12:00 ET

Fangsheng Pharmaceutical: Fangsheng Pharmaceutical\'s business data announcement for the first three quarters of 2024

Oct 28 12:00 ET

Fangsheng Pharmaceutical: Announcement of Resolutions of the 14th Meeting of the Fifth Board of Supervisors of Fangsheng Pharmaceutical

Oct 28 12:00 ET

Announcement of Resolutions of the 14th Meeting of the Fifth Board of Supervisors of Fangsheng Pharmaceutical

Oct 28 12:00 ET

Fangsheng Pharmaceutical: Announcement of Resolutions of the Eighth Interim Meeting of the Fifth Board of Directors of Fangsheng Pharmaceutical in 2024

Oct 23 12:00 ET

Fangsheng Pharmaceutical: Articles of Association of Fangsheng Pharmaceutical Company (to be submitted to the company\'s shareholders\' meeting for consideration)

Oct 23 12:00 ET

Fangsheng Pharmaceutical: Announcement of Resolutions of the Eighth Interim Meeting of the 5th Fangsheng Pharmaceutical Supervisory Board in 2024

Oct 23 12:00 ET

Fangsheng Pharmaceutical: Fangsheng Pharmaceutical\'s Announcement on the Transfer of Drug Ownership

Oct 23 12:00 ET

Fangsheng Pharmaceutical: Fangsheng Pharmaceutical Securities Investment Management System (reviewed and approved by the 8th Interim Meeting of the 5th Board of Directors in 2024)

Oct 23 12:00 ET

Announcement of Resolutions of the Eighth Interim Meeting of the Fifth Board of Supervisors of Fangsheng Pharmaceutical in 2024

Oct 23 12:00 ET

Articles of Association of Fangsheng Pharmaceutical Company (to be submitted to the company\'s shareholders\' meeting for consideration)

Oct 23 12:00 ET

Fangsheng Pharmaceutical Securities Investment Management System (reviewed and approved by the 5th Board of Directors at the 8th Interim Meeting in 2024)

Oct 23 12:00 ET

Announcement of Resolutions of the Eighth Interim Meeting of the Fifth Board of Directors of Fangsheng Pharmaceutical in 2024

Oct 23 12:00 ET

Fangsheng Pharmaceutical\'s announcement on holding a performance briefing for the third quarter of 2024

Oct 14 12:00 ET

Fangsheng Pharmaceutical: Investor Relations Activity Record Form (2024-037)

Oct 10 21:30 ET

Fangsheng Pharmaceutical: Investor Relations Activity Record Form (2024-035, 36)

Sep 29 22:35 ET

Fangsheng Pharmaceutical\'s dividend management system (reviewed and approved by the 2nd Extraordinary General Meeting of Shareholders in 2024)

Sep 27 12:00 ET

Announcement of Fangsheng Pharmaceutical on participating in the 2024 Investor Online Group Reception Day in Hunan

Sep 24 12:00 ET